• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌细胞色素P450:天然植物化学物质的化学预防和/或治疗靶点

Breast Cancer Cytochromes P450: Chemopreventive and/or Therapeutic Targets for Naturally Occurring Phytochemicals.

作者信息

Szaefer Hanna, Licznerska Barbara, Sobierajska Hanna, Baer-Dubowska Wanda

机构信息

Department of Pharmaceutical Biochemistry, Poznan University of Medical Sciences, 60-806 Poznań, Poland.

出版信息

Molecules. 2025 Jul 23;30(15):3079. doi: 10.3390/molecules30153079.

DOI:10.3390/molecules30153079
PMID:40807256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12348687/
Abstract

Estrogens are considered the most important risk factor for the development of breast cancer. Therefore, attempts are being made to reduce their level through diminished synthesis on one hand and to protect against the formation of DNA-damaging estrogen metabolites on the other. Cytochromes P450 (CYPs) play key roles in estrogen synthesis and catabolism, leading to potentially carcinogenic metabolites. CYP19 (aromatase) catalyzes the conversion of androgens to estrogens. The estrogen receptor-dependent pathway induces cell growth. CYP1 family enzymes, particularly CYP1B1, are involved in the redox cycling of estrogen metabolites and the subsequent estrogen-DNA adducts formation. Naturally occurring phytochemicals of different classes were shown to modulate the CYP expression and activity in cell-free systems or breast cancer cells. One of the most promising CYP19 inhibitors is chrysin (flavone), while stilbenes seem to be the most effective CYP1B1 inhibitors. In most cases, their effect is not specific. Therefore, different approaches are made to find the best candidate for the drug prototype of a new therapeutic or chemopreventive agent and to improve its pharmacokinetic parameters. This review presents and discusses the possible effects on major CYPs involved in estrogen metabolism by phytochemicals from the most investigated classes, namely flavonoids, stilbenes, and glucosinolates breakdown products.

摘要

雌激素被认为是乳腺癌发生的最重要风险因素。因此,一方面人们试图通过减少合成来降低其水平,另一方面试图防止形成具有DNA损伤作用的雌激素代谢产物。细胞色素P450(CYPs)在雌激素合成和分解代谢中起关键作用,会产生潜在的致癌代谢产物。CYP19(芳香化酶)催化雄激素向雌激素的转化。雌激素受体依赖性途径可诱导细胞生长。CYP1家族酶,尤其是CYP1B1,参与雌激素代谢产物的氧化还原循环以及随后雌激素-DNA加合物的形成。不同种类的天然植物化学物质已被证明可在无细胞系统或乳腺癌细胞中调节CYP的表达和活性。最有前景的CYP19抑制剂之一是白杨素(黄酮),而芪类似乎是最有效的CYP1B1抑制剂。在大多数情况下,它们的作用并不具有特异性。因此,人们采用了不同的方法来寻找新型治疗或化学预防药物原型的最佳候选物,并改善其药代动力学参数。本综述介绍并讨论了来自研究最多的几类植物化学物质,即黄酮类、芪类和硫代葡萄糖苷分解产物,对参与雌激素代谢的主要CYPs可能产生的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0760/12348687/00d8088d8add/molecules-30-03079-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0760/12348687/d2e1da7bb133/molecules-30-03079-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0760/12348687/f47a99b8fcea/molecules-30-03079-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0760/12348687/7e485580b37a/molecules-30-03079-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0760/12348687/00d8088d8add/molecules-30-03079-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0760/12348687/d2e1da7bb133/molecules-30-03079-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0760/12348687/f47a99b8fcea/molecules-30-03079-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0760/12348687/7e485580b37a/molecules-30-03079-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0760/12348687/00d8088d8add/molecules-30-03079-g004.jpg

相似文献

1
Breast Cancer Cytochromes P450: Chemopreventive and/or Therapeutic Targets for Naturally Occurring Phytochemicals.乳腺癌细胞色素P450:天然植物化学物质的化学预防和/或治疗靶点
Molecules. 2025 Jul 23;30(15):3079. doi: 10.3390/molecules30153079.
2
Curcumin as an antidote to atrazine on estrogen homeostasis and beyond: mechanistic insights from a targeted literature review.姜黄素作为阿特拉津对雌激素稳态及其他方面影响的解毒剂:基于针对性文献综述的机制见解
Front Endocrinol (Lausanne). 2025 Jul 23;16:1553465. doi: 10.3389/fendo.2025.1553465. eCollection 2025.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
5
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
6
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.促黄体生成素释放激素激动剂用于绝经前女性早期乳腺癌的辅助治疗。
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD004562. doi: 10.1002/14651858.CD004562.pub4.
8
Trastuzumab-containing regimens for metastatic breast cancer.用于转移性乳腺癌的含曲妥珠单抗方案。
Cochrane Database Syst Rev. 2014 Jun 12;2014(6):CD006242. doi: 10.1002/14651858.CD006242.pub2.
9
The melanin inhibitory effect of plants and phytochemicals: A systematic review.植物和植物化学物质的黑色素抑制作用:系统评价。
Phytomedicine. 2022 Dec;107:154449. doi: 10.1016/j.phymed.2022.154449. Epub 2022 Sep 6.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
Breast cancer statistics 2024.2024 年乳腺癌统计数据。
CA Cancer J Clin. 2024 Nov-Dec;74(6):477-495. doi: 10.3322/caac.21863. Epub 2024 Oct 1.
2
Honokiol Exhibits Anti-Tumor Effects in Breast Cancer by Modulating the miR-148a-5p-CYP1B1 Axis.和厚朴酚通过调节 miR-148a-5p-CYP1B1 轴发挥抗肿瘤作用。
Am J Chin Med. 2024;52(6):1843-1861. doi: 10.1142/S0192415X24500721. Epub 2024 Sep 30.
3
The Aryl Hydrocarbon Receptor and Its Crosstalk: A Chemopreventive Target of Naturally Occurring and Modified Phytochemicals.
芳基烃受体及其串扰:天然存在和修饰植物化学物质的化学预防靶点。
Molecules. 2024 Sep 10;29(18):4283. doi: 10.3390/molecules29184283.
4
Updates on Mechanisms of Cytochrome P450 Catalysis of Complex Steroid Oxidations.甾体化合物复杂氧化反应中细胞色素 P450 催化机制的最新研究进展。
Int J Mol Sci. 2024 Aug 20;25(16):9020. doi: 10.3390/ijms25169020.
5
There and Back Again: A Perspective on 20 Years of CYP4Z1.《往返之间:对 CYP4Z1 二十年研究的看法》。
Drug Metab Dispos. 2024 May 16;52(6):498-507. doi: 10.1124/dmd.124.001670.
6
Evaluating flavonoids as potential aromatase inhibitors for breast cancer treatment: In vitro studies and in silico predictions.评估黄酮类化合物作为治疗乳腺癌的潜在芳香酶抑制剂:体外研究和计算机预测。
Chem Biol Interact. 2024 Apr 1;392:110927. doi: 10.1016/j.cbi.2024.110927. Epub 2024 Feb 24.
7
Polymethoxylated flavonoids in citrus fruits: absorption, metabolism, and anticancer mechanisms against breast cancer.柑橘类水果中的多甲氧基黄酮:吸收、代谢和抗癌机制对乳腺癌的作用。
PeerJ. 2024 Jan 3;12:e16711. doi: 10.7717/peerj.16711. eCollection 2024.
8
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer.乳腺癌中雌激素受体信号通路的基础研究综述
Int J Mol Sci. 2023 Apr 6;24(7):6834. doi: 10.3390/ijms24076834.
9
Human Orphan Cytochromes P450: An Update.人类孤儿细胞色素P450:最新进展
Curr Drug Metab. 2022;23(12):942-963. doi: 10.2174/1389200224666221209153032.
10
Human Orphan Cytochrome P450 2U1 Catalyzes the ω-Hydroxylation of Leukotriene B.人源细胞色素 P450 2U1 酶催化白三烯 B 的 ω-羟化反应。
Int J Mol Sci. 2022 Nov 23;23(23):14615. doi: 10.3390/ijms232314615.